Publications by authors named "Kay Wilkinson"

Claim this Profile
I
Intangible costs and benefits of ulcerative colitis surveillance: a patient survey.
Matthew D Rutter, Brian P Saunders, Kay H Wilkinson, Gillian Schofield, Alastair Forbes

Dis Colon Rectum· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis.
Matthew D Rutter, Brian P Saunders, Kay H Wilkinson, Steve Rumbles, Gillian Schofield

Gastroenterology· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new prognostic staging system for rectal cancer.
Hideki Ueno, Ashley B Price, Kay H Wilkinson, Jeremy R Jass, Hidetaka Mochizuki

Ann Surg· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Most dysplasia in ulcerative colitis is visible at colonoscopy.
Matthew D Rutter, Brian P Saunders, Kay H Wilkinson, Michael A Kamm, Christopher B Williams

Gastrointest Endosc· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.
Matthew Rutter, Brian Saunders, Kay Wilkinson, Steve Rumbles, Gillian Schofield

Gastroenterology· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the structure and DNA-binding properties of the E2 proteins from an oncogenic and a non-oncogenic human papillomavirus.
Ghislaine Dell, Kay W Wilkinson, Rebecca Tranter, Joanna Parish, R Leo Brady

J Mol Biol· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PRO_SELECT: combining structure-based drug design and array-based chemistry for rapid lead discovery. 2. The development of a series of highly potent and selective factor Xa inhibitors.
John W Liebeschuetz, Stuart D Jones, Phillip J Morgan, Chris W Murray, Andrew D Rimmer, Kay Wilkinson

J Med Chem· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis